Another option includes purchase of vaccines for the undersured no matter where they are served.
One of the working group’s recommendations suggests that the Vaccines For Children (VFC) Program expand to include purchase of vaccines for underinsured children and adolescents who are served in public health clinics. Only Medicaid offers an administration fee for these children and the levels of Medicaid fees vary substantially from state to state with some reimbursements less than $3 per dose administered. Through the Vaccines for Children (VFC) program, the public sector purchases vaccines for children on Medicaid, children without insurance and children who are American Indians/Alaska Natives. In addition, it includes public sector payments to private providers for administration of publicly purchased vaccines for children. This includes purchase of vaccines for children who have traditionally relied on the public sector, particularly underinsured children served at public health clinics. Public sector issuesĪccording to Orenstein, the greatest problem appears to be in public sector financing. “Right now, there are a variety of stakeholder groups that are being represented, and thus far, we have not been able to reach a consensus on some of the most fundamental issues,” Orenstein said. Orenstein acknowledged the substantial problem with vaccine financing in both the public and private sectors and presented a draft of 27 options for recommendations to be considered for the group’s white paper at the recent NVAC meeting. But the NVAC will forge ahead, and if a consensus of the workgroup cannot be reached, the NVAC itself will make recommendations by majority vote.” However, the stakeholders on the workgroup, including representatives of private providers, government, manufacturers and distributors, insurers, employers, consumers and others have very different takes on a number of the vaccine financing issues, and we realize that developing a set of recommendations may be very difficult.
“NVAC recognizes that there is a financing problem and will make recommendations that will hopefully solve these problems. Orenstein, MD, of the Emory Vaccine Center and member of the Infectious Diseases in Children editorial board, said in an interview. “What providers need to know is that NVAC is taking financing very seriously,” Walter A. WASHINGTON - The National Vaccine Advisory Committee’s Vaccine Financing Working Group proposed a new set of options for the committee to consider as solutions to address vaccine financing problems. If you continue to have this issue please contact to Healio
0 kommentar(er)
